Novel Compound Activates Key Psychedelic Receptor Without Behavioral Effects

Laboratory tests of a novel serotonin-binding compound have revealed an unexpected disconnect between receptor activation and behavior, raising new questions about how psychedelic effects emerge in the brain. In past studies, psychedelic drugs have usually produced a predictable behavioral response in mice . Activation of the brain’s serotonin 5-HT2A receptor typically leads to rapid head-twitch movements, which researchers use as a standard indicator of hallucinogenic effects. When scientists administered a newly synthesized compound known as D5 to mice , this response did not occur. Although D5 activated the same receptor associated with classic psychedelics , it did not cause head-twitch behavior. This result was unexpected for neuroscientists who study the connection between perception and serotonin signaling. Researchers at the University of California-Davis and other collaborating institutions reported the finding in the Journal of the American Chemical Society . It raises a basic but unresolved question about how closely psychedelic effects are tied to the brain pathways believed to produce them. Psychedelic Signaling Behavior The 5-HT2A receptor is a central focus in psychedelic neuroscience. Well-known compounds like LSD and psilocybin bind to these receptors in the brain’s cortex, changing neural signaling in ways that can alter perception and shift consciousness. This
Read More